Shih‐Che Hua

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly

Shih‐Che Hua, Yuan‐Horng Yan, Tien‐Chun Chang · European Journal of Endocrinology · 2006 · 70 citations

High TSH Level within Normal Range Is Associated with Obesity, Dyslipidemia, Hypertension, Inflammation, Hypercoagulability, and the Metabolic Syndrome: A Novel Cardiometabolic Marker

Yi‐Cheng Chang, Shih‐Che Hua, Chia‐Hsuin Chang et al. · Journal of Clinical Medicine · 2019 · 65 citations · Full text

Reversine, a 2,6-disubstituted Purine, as an Anti-cancer Agent in Differentiated and Undifferentiated Thyroid Cancer Cells

Shih‐Che Hua, Tien‐Chun Chang, Hau‐Ren Chen et al. · Pharmaceutical Research · 2012 · 46 citations

Medicine, Anti-cancer Agent, Thyroid Hormone +5